James Hagedorn SMG Form 4: 23% Control Check

James Hagedorn is back in the Form 4 tape at Scotts Miracle-Gro, but the latest filing is not the simple sale headline that his long career history can tempt investors to write. The June report, SEC accession 0001180171-26-000017, shows a 2,771.346-share phantom-stock award on June 5 and a small 39.58-share common-stock entry dated May 29 at $50.53. It does not show a new open-market sale by the chairman and CEO.

That distinction matters because Hagedorn is not just another officer with a compensation form. He is the controlling-family executive at SMG, and the ownership trail runs through direct common shares, a 401(k) plan, Hagedorn Partnership, phantom stock and a separate Schedule 13D/A. The platform's career record for Hagedorn's insider history shows roughly $312.5 million of reported sale value since 2004, but the June 2026 document is a control-and-compensation filing, not a fresh discretionary exit.

The outside context is timely. Scotts is trying to leave the cannabis-supply overhang behind, rebuild margins in core lawn and garden, and set up shareholder returns after years of balance-sheet repair. The company said second-quarter fiscal 2026 sales rose 5% to $1.46 billion, adjusted gross margin improved by more than 200 basis points, and net leverage fell to 3.71 times from 4.41 times a year earlier. It also completed the Hawthorne divestiture in April, removing the volatile cannabis-adjacent hydroponics subsidiary from continuing operations.

What the June Form 4 actually says

The newest filing is best read line by line. In Table I, the non-derivative section, Hagedorn reported 39.58 common shares with transaction code J, an other transaction, at $50.53. The filing marks the transaction form type as 5 and leaves the reader with 88,670.3308 directly held common shares after the line. It also reports 31,533.64 common shares held indirectly by a 401(k) plan and 997,910 common shares associated with Hagedorn Partnership, L.P.

In Table II, the derivative section, the filing reports 2,771.346 phantom shares acquired with transaction code A. A Form 4 A code is an award or grant, not a market purchase. The footnote says each phantom share represents the right to receive one common share of Scotts Miracle-Gro or the cash value, and that the phantom stock is payable in cash after Hagedorn's employment ends. The filing lists 244,177.774 phantom shares beneficially owned after the transaction.

There is also a motive check. The filing's Rule 10b5-1 checkbox is not the reason for a sale here because there is no S-code sale to interpret. A separate December 2025 Schedule 13D/A references a 10b5-1 plan for Katherine Hagedorn Littlefield covering periodic sales of up to 130,000 shares beginning December 18, 2025, but that is not the same as saying James Hagedorn made a new discretionary sale. The safer reading is narrower: this filing updates compensation-linked and indirect ownership data inside a family-control structure.

The ownership check is the story

The ownership cross-check is why the latest James Hagedorn profile is more useful than a one-line transaction alert. The Form 4 identifies Hagedorn as director, officer and more-than-10% owner. The Hagedorn Partnership footnote says he may be deemed, solely for Section 16 beneficial-owner purposes, to own securities held by the partnership because he is a general partner, and it describes the figure as his aggregate proportionate interest and that of family members in whose holdings he may have a pecuniary interest.

The 13D layer pushes that point further. A December 11, 2025 Schedule 13D/A by Hagedorn Partnership, L.P. listed 13,217,641 shares beneficially owned by the partnership, or 22.8% of the class based on 57,995,369 outstanding shares. The same filing materials put James Hagedorn in the roughly 23.0% beneficial-ownership discussion. That is the control frame investors need before reacting to any single Table I number.

It also explains why the institutional holder map should be read as context, not as a replacement for the family-control story. BlackRock reported 4.44 million SMG shares in the latest 13F holder view, while Earnest Partners reported 3.40 million. FMR, Ameriprise Financial, Arrowstreet Capital, Ariel Investments and State Street all sit in the holder base too. Those positions show liquidity and institutional sponsorship, but the Hagedorn family stake is the governance variable.

Why this lands during a strategic reset

Scotts is in a cleaner, sharper phase than it was during the cannabis boom and bust. The Hawthorne sale to Vireo Growth closed in April 2026, and Scotts said the divestiture supports margin recovery and lets management focus on branded consumer lawn and garden. In the second-quarter release, Hagedorn tied the improvement in leverage to future shareholder-friendly actions, including the previously announced multi-year repurchase program.

That timing makes the Form 4 relevant even without a sale. A family-controlled CEO receiving phantom stock and maintaining layered ownership is different from a hired executive trimming a small residual position. Hagedorn's incentives sit beside a company that says leverage is back in the high-3s zone, fiscal 2026 guidance is intact, free cash flow is expected to reach $275 million, and buybacks are intended to begin later in fiscal 2026. If those targets hold, the family-control structure has a direct line into capital allocation.

The holder base adds another tension. Active managers such as Earnest Partners' SMG position and Ariel Investments' SMG stake are watching a company that still has debt, seasonality and commodity-cost exposure. Passive and quasi-passive holders are present as well, so a headline institutional count does not automatically mean active conviction. The more actionable lens is whether Scotts keeps leverage in the 3-times range while improving margins after Hawthorne.

What investors should watch next

The next verifiable anchor is fiscal 2026 execution, not a vague hope for more filings. Scotts has already said it expects U.S. Consumer low-single-digit sales growth, non-GAAP adjusted gross margin of at least 32%, adjusted EPS from continuing operations of $4.15 to $4.35, mid-single-digit adjusted EBITDA growth and $275 million of free cash flow. The Form 4 should be tracked against those targets and against any future 13D/A updates from Hagedorn Partnership.

For insider-trading readers, the key rule is simple: separate codes before drawing motive. A, J, M and F codes can be compensation, administrative, exercise or tax mechanics. S-code open-market sales require their own review for size, timing and 10b5-1 footnotes. On this latest filing, Hagedorn's Form 4 record says control context first, sale narrative second.

FAQ

Why did James Hagedorn file a new SMG Form 4?

James Hagedorn filed because his latest report showed a 2,771-share phantom-stock award and a small 401(k)-related common-share entry, not an open-market sale.

How much SMG did James Hagedorn own after the filing?

The Form 4 listed 88,670 direct common shares, 31,533.64 shares through a 401(k) plan, 997,910 shares tied to Hagedorn Partnership, and 244,177.774 phantom shares.

Is the latest Hagedorn SMG filing a bearish insider sale?

No. The latest filing does not report a discretionary open-market sale by James Hagedorn, so the cleaner read is compensation and ownership structure rather than a bearish trading signal.

Why does the Hagedorn family stake matter for SMG investors?

A December 2025 Schedule 13D/A showed Hagedorn Partnership and related reporting persons around a 22.8% to 23.0% beneficial ownership range, making family control central to any SMG Form 4 interpretation.